Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
10/17/2025 | PUT | $2.50 | 24 | +4 | +20.00% |
12/19/2025 | CALL | $2.50 | 2,379 | 0 | |
12/19/2025 | CALL | $5.00 | 1,491 | 0 | |
12/19/2025 | PUT | $2.50 | 746 | 0 | |
12/19/2025 | PUT | $5.00 | 122 | 0 | |
09/19/2025 | CALL | $2.50 | 727 | 0 | |
03/20/2026 | PUT | $7.50 | 0 | 0 | |
10/17/2025 | CALL | $2.50 | 0 | 0 | |
10/17/2025 | CALL | $5.00 | 0 | 0 | |
10/17/2025 | CALL | $7.50 | 0 | 0 | |
10/17/2025 | PUT | $5.00 | 0 | 0 | |
10/17/2025 | PUT | $7.50 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard International Stock Index-Total Intl Stock Indx | 1.10% | 951.94k | 1.19M |
Delaware Group Equity Fds IV-Delaware Healthcare Fund | 0.98% | 852.94k | 1.07M |
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 0.66% | 573.94k | 717.42k |
PFS Funds-Taylor Frigon Core Growth Fund | 0.32% | 279.21k | 349.01k |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 0.32% | 277.24k | 346.55k |
DFA Continental Small Company Series | 0.13% | 113.94k | 142.43k |
SPDR Portfolio Developed World ex-US ETF | 0.10% | 87.69k | 109.61k |
Parametric International Equity Fund | 0.08% | 65k | 81.25k |
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.07% | 61.56k | 76.95k |
Vanguard Intl Equity Index - Total World Stock Index Fd | 0.04% | 36.69k | 45.87k |
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
07/02 09:22 am
Zacks Investment Research
Read moreFDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease
07/01 10:31 am
Zacks Investment Research
Read moreApellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
07/01 08:44 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
07/01 08:00 am
Zacks Investment Research
Read moreCogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting
06/28 09:18 am
Zacks Investment Research
Read moreMerck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
06/28 07:28 am
Zacks Investment Research
Read moreNovo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal
06/27 10:22 am
Zacks Investment Research
Read moreCASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
06/27 09:42 am
Zacks Investment Research
Read moreBayer's (BAYRY) AskBio Advances Parkinson Disease Study
06/26 01:58 pm
Zacks Investment Research
Read moreImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why
06/26 09:41 am
Zacks Investment Research
Read moreAlnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
06/25 08:59 am
Zacks Investment Research
Read moreShould You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
06/20 08:23 am
Zacks Investment Research
Read moreDay One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up
06/19 10:29 am
Zacks Investment Research
Read moreIntra-Cellular (ITCI) Up as Second Depression Study Meets Goals
06/19 10:27 am
Zacks Investment Research
Read moreAerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
06/18 09:21 am
Zacks Investment Research
Read moreApellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
06/11 09:48 am
Zacks Investment Research
Read moreChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
06/10 09:45 am
Zacks Investment Research
Read moreRepare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
06/06 09:59 am
Zacks Investment Research
Read moreAnnexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals
06/05 10:57 am
Zacks Investment Research
Read moreIntellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
06/04 11:21 am
Zacks Investment Research
Read moreCompugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
06/04 09:55 am
Zacks Investment Research
Read moreCompugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
05/20 08:10 am
Zacks Investment Research
Read moreAre You Looking for a Top Momentum Pick? Why Compugen (CGEN) is a Great Choice
03/12 12:00 pm
Zacks Investment Research
Read moreBOX Gears Up to Report Q4 Earnings: Here's What to Expect
03/04 11:55 am
Zacks Investment Research
Read moreWill Petrobras (PBR) Report Q4 Earnings Beat on Output Gains?
03/04 09:42 am
Zacks Investment Research
Read moreIs a Surprise Coming for Compugen (CGEN) This Earnings Season?
02/29 09:58 am
Zacks Investment Research
Read morePuma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
02/27 12:51 pm
Zacks Investment Research
Read moreBaidu (BIDU) to Report Q4 Earnings: What's in the Offing?
02/27 11:29 am
Zacks Investment Research
Read moreVipshop (VIPS) to Post Q4 Earnings: What's in the Offing?
02/27 11:25 am
Zacks Investment Research
Read moreACM Research (ACMR) to Report Q4 Earnings: What's in Store?
02/27 09:57 am
Zacks Investment Research
Read moreWhat to Look for in Crescent Point's (CPG) Q4 Earnings?
02/27 08:13 am
Zacks Investment Research
Read moreAgilent Technologies (A) to Post Q1 Earnings: What's in Store?
02/26 01:23 pm
Zacks Investment Research
Read moreWhat's in Store for Qurate Retail (QRTEA) in Q4 Earnings?
02/26 11:17 am
Zacks Investment Research
Read moreGinkgo (DNA) to Report Q4 Earnings: What's in the Cards?
02/26 10:18 am
Zacks Investment Research
Read moreEton Pharma (ETON) to Report Q4 Earnings: What's in the Cards?
02/26 09:19 am
Zacks Investment Research
Read moreCompugen (CGEN) is a Great Momentum Stock: Should You Buy?
02/21 01:00 pm
Zacks Investment Research
Read moreBiotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
12/21 12:39 pm
Zacks Investment Research
Read moreGilead (GILD), Compugen Collaborate for Immunotherapy Program
12/20 11:33 am
Zacks Investment Research
Read moreCompugen's stock rockets on deal with Gilead for anti-tumor drug
12/19 11:52 am
MarketWatch
Read moreUS Stocks Higher; Accenture Issues Weak Sales Outlook
12/19 10:42 am
Benzinga
Read moreIs Compugen (CGEN) Outperforming Other Medical Stocks This Year?
12/05 10:40 am
Zacks Investment Research
Read moreThese Israeli pharmaceutical stocks are down in the wake of Hamas attack
10/09 09:51 am
MarketWatch
Read moreKaruna (KRTX) Submits NDA Filing to FDA for Schizophrenia Drug
09/29 12:32 pm
Zacks Investment Research
Read moreIs Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
09/14 09:40 am
Zacks Investment Research
Read moreHas Compugen (CGEN) Outpaced Other Medical Stocks This Year?
08/29 09:40 am
Zacks Investment Research
Read more5 Analysts Have This to Say About Compugen
08/07 01:00 pm
Benzinga
Read moreExpert Ratings for Compugen
05/26 01:00 pm
Benzinga
Read more